// App-Quantinova.ai

PB0070 : Vaccine Induced Thrombotic Thrombocytopenia post Dose 2 ChAdOx1 nCoV19 vaccination: less severe but not void of catastrophic outcomes

Researchers

Presenter

  • L. Clarke

Principal Investigators

  • H. Tran

  • J. Curnow

  • S. Chunilal

  • T. Brighton

  • F. Passam

  • C. Lee

  • D. Donikian

  • M. Kondo

  • V. CHEN

Medical Centers

  • Department of Haematology, Concord Repatriation General Hospital; Australian Red Cross Lifeblood, Sydney Adventist Hospital, Concord, New South Wales, Australia

  • Department of Clinical Hematology, The Alfred Hospital, Melbourne, Australia AND Department of Medicine, Central Clinical School, Monash University, Melbourne, Australia, Melbourne, Victoria, Australia

  • Director Clinical Haematology WSLHD, Senior Staff Specialist, Westmead hospital Director Westmead Haemophilia Treatment Centre Clinical Assoc. Professor in Discipline of Medicine, Faculty of Medicine and Health, University of Sydney, Westmead, New South Wales, Australia

  • Concord Repatriation General Hospital, Concord, NSW, Australia

  • Monash Health, Clayton, Australia

  • Department Haematology, New South Wales Health Pathology, Prince of Wales Hospital, Sydney, New South Wales, Australia

  • Royal Prince Alfred Hospital; Haematology Research Group, The Heart Research Institute, Faculty of Medicine & Health, Central Clinical School, University of Sydney, Sydney, New South Wales, Australia

  • ANZAC Research Institute, University of Sydney, Sydney, NSW, Australia

  • ANZAC Research Institute, University of Sydney; Department of Haematology, Concord Repatriation General Hospital, Sydney, New South Wales, Australia

Locations

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

Disease

  • Thrombocytopenia

  • Venous thrombosis

Biomarkers

  • Immunoglobulin G

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A